The global AI-based clinical trials solution provider market is on the verge of remarkable expansion, with projections estimating its value at USD 2.2 billion in 2024, skyrocketing to USD 8.7 billion by 2034. This impressive growth trajectory is expected to follow a robust compound annual growth rate (CAGR) of 14.3% from 2024 to 2034, reflecting …